PTEN (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase) contains a tensin-like domain and a catalytic domain similar to the dual specificity protein tyrosine phosphatases. It was identified as a tumor suppressor mutated in many cancers, including sporadic brain, breast, endometrial, kidney, and prostate cancers.